Vaccine can induce CD4-mediated responses to homocitrullinated peptides via multiple HLA-types and confer anti-tumor immunity KW Cook, W Xue, S Atabani, P Symonds, A Al Omari, I Daniels, S Shah, ... Frontiers in Immunology, 1490, 2022 | 7 | 2022 |
What do cancer-specific T cells ‘see’? S Shah, A Al-Omari, KW Cook, SJ Paston, LG Durrant, VA Brentville Discovery Immunology 2 (1), kyac011, 2023 | 5 | 2023 |
Citrullinated glucose-regulated protein 78 is a candidate target for melanoma immunotherapy VA Brentville, P Symonds, JX Chua, A Skinner, I Daniels, KW Cook, ... Frontiers in Immunology 13, 1066185, 2022 | 5 | 2022 |
Immune responses to citrullinated and homocitrullinated peptides in healthy donors are not restricted to the HLA SE shared allele and can be selected into the memory pool RH Choudhury, I Daniels, P Vaghela, S Atabani, T Kirk, P Symonds, ... Immunology, 2023 | 3 | 2023 |
Vaccination with post-translational modified, homocitrullinated peptides induces CD8 T-cell responses that mediate antitumor immunity S Shah, KW Cook, P Symonds, J Weißer, A Skinner, A Al Omari, ... Journal for ImmunoTherapy of Cancer 11 (10), e006966, 2023 | 2 | 2023 |
Modi-2 a vaccine stimulating CD4 responses to homocitrullinated self epitopes as therapy for solid cancers AA Al-Omari, KW Cook, P Symonds, A Skinner, A Wright, Y Zhu, VL Coble, ... npj Vaccines 9 (1), 236, 2024 | | 2024 |
Identification of distinct markers to differentiate natural and induced T regulatory cells in cancer A Al-Omari PQDT-Global, 2019 | | 2019 |